Skip to content
DefDex

Federal award

ELUSYS THERAPEUTICS INC

W9113M10C0024

Contract

Obligated and Ceiling

Obligated (net)
$734,898.00
Ceiling (potential value, not spending)
$735,626.00
Current value
$735,626.00
Gross positive obligations
$735,626.00

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
ELUSYS THERAPEUTICS INC · ELP1DCK8L191
Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
ELUSYS THERAPEUTICS INC · ELP1DCK8L191
Awarding agency
Department of War · sub-agency 2100 · office W9113M
Funding agency
Department of War · sub-agency 2100
Product or service (PSC)
AN13 · HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT
Industry (NAICS)
541711 · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY
PIID
W9113M10C0024
Award type code
D
Actions
7 · May 17, 2010 to May 27, 2014
Why it is listed
gross positive obligations of $100k or more (contracts)

Open this award on USAspending →

Action History7

Award actions
DateFYModAction typeObligationCompany in company totals
May 27, 2014FY2014P00006C−$728.00
—
Sep 10, 2012FY2012P00005B$0.00
—
Feb 8, 2012FY2012P00004B$0.00
—
Dec 29, 2011FY2012P00003B$0.00
—
Feb 25, 2011FY2011P00002M$0.00
—
Aug 2, 2010FY2010P00001B$248,197.00
—
May 17, 2010FY20100—$487,429.00
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.